Zhang Bin, Xie Wen, Krasowski Matthew D
Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Pharmacogenomics. 2008 Nov;9(11):1695-709. doi: 10.2217/14622416.9.11.1695.
The pregnane X receptor (PXR; NR1I2), a member of the nuclear receptor superfamily, regulates the expression of drug-metabolic enzymes and transporters involved in the responses of mammals to their chemical environment. The same enzyme and transporter systems are also involved in the homeostasis of numerous endogenous chemicals. The regulatory function of PXR is implicated in normal physiology and diseases, such as drug-drug interactions, hepatic steatosis, vitamin D homeostasis, bile acids homeostasis, steroid hormones homeostasis and inflammatory bowel diseases. As such, any genetic variations of this receptor could potentially have widespread effects on the disposition of xenobiotics and endobiotics. Knowledge concerning the genetic polymorphisms of PXR may help to understand the variations in human drug response and ensure safe drug use. The correlation of PXR genetic polymorphisms with several disease conditions also suggests that this receptor may represent a valid therapeutic for hepato-intestinal disorders such as inflammatory bowel disease and primary sclerosing cholangitis.
孕烷X受体(PXR;NR1I2)是核受体超家族的成员,可调节参与哺乳动物对其化学环境反应的药物代谢酶和转运蛋白的表达。相同的酶和转运蛋白系统也参与多种内源性化学物质的稳态。PXR的调节功能与正常生理和疾病有关,如药物相互作用、肝脂肪变性、维生素D稳态、胆汁酸稳态、类固醇激素稳态和炎症性肠病。因此,该受体的任何基因变异都可能对异生物素和内生物素的处置产生广泛影响。有关PXR基因多态性的知识可能有助于理解人类药物反应的差异并确保安全用药。PXR基因多态性与几种疾病状况的相关性还表明,该受体可能是治疗炎症性肠病和原发性硬化性胆管炎等肝肠疾病的有效药物。